PASITHEA THERAPEUTICS CORP. Increase (Decrease) in Other Current Assets
PASITHEA THERAPEUTICS CORP. (KTTA) reported Increase (Decrease) in Other Current Assets of -$365.28 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-14
- PASITHEA THERAPEUTICS CORP. increase (decrease) in other current assets for the quarter ending 2026-06-30 was -$377.93K.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in other current assets for the quarter ending 2026-03-31 was $12.65K, a 35.17% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in other current assets for the quarter ending 2025-12-31 was $379.16K, a 749.90% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in other current assets for the quarter ending 2025-09-30 was -$84.78K.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in other current assets for fiscal 2025 was $269.28K.
- PASITHEA THERAPEUTICS CORP. increase (decrease) in other current assets for fiscal 2024 was -$2.26K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$377.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$365.28K 10-Q · filed 2026-08-14 | $13.88K derived: sum of 3 quarters · filed 2026-08-14 | -$70.90K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $12.65K 10-Q · filed 2026-05-15 | $391.81K derived: sum of 2 quarters · filed 2026-05-15 | $307.03K derived: sum of 3 quarters · filed 2026-05-15 | $262.42K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $379.16K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $294.38K derived: sum of 2 quarters · filed 2026-03-30 | $249.77K derived: sum of 3 quarters · filed 2026-08-14 | $269.28K 10-K · filed 2026-03-30 |
| 2025-09-30 | -$84.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$129.39K derived: sum of 2 quarters · filed 2026-08-14 | -$109.88K 10-Q · filed 2025-11-13 | -$65.27K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$44.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$25.10K 10-Q · filed 2026-08-14 | $19.51K derived: sum of 3 quarters · filed 2026-08-14 | $13.19K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $19.51K 10-Q · filed 2026-05-15 | $64.12K derived: sum of 2 quarters · filed 2026-05-15 | $57.80K derived: sum of 3 quarters · filed 2026-05-15 | $17.30K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $44.61K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $38.29K derived: sum of 2 quarters · filed 2026-03-30 | -$2.20K derived: sum of 3 quarters · filed 2026-03-30 | -$2.26K 10-K · filed 2026-03-30 |
| 2024-09-30 | -$6.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$46.82K derived: sum of 2 quarters · filed 2025-11-13 | -$46.87K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$40.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$40.55K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | -$58.00 10-Q · filed 2025-05-15 | |||
| 2023-09-30 | -$345.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$156.48K 10-Q · filed 2023-11-13 | ||
| 2023-06-30 | $189.20K 10-Q · filed 2023-08-11 | |||
| 2022-09-30 | $574.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $621.28K 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $46.59K 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |